Detection of tumor-associated antigen in human melanoma cell line supernatants.
Spent tissue culture medium (CDM-S) removed from a single cell line of human malignant melanoma grown in serum-free CDM, contained tumor-associated antigenic activity. Antibodies to CDM-S measured by complement fixation were detected in 44% (31/70) melanoma, 55% (15/27) sarcoma, 63% (24/38) carcinoma and 15% (11/72) normal sera. Delayed cutaneous hypersensitivity reactions (DCHR) were demonstrated in 4/5 melanoma patients at a 500 mug dose, 3/5 at a 100 mug dose and in 1/7 carcinoma patients at the 500 mug dose. One ml of CDM-S was shown to contain antigen equivalent to that obtained from the membranes of 2.9 X 10(7) tissue-cultured melanoma cells. After purification, 84% (16/19) sera from melanoma patients, 66% (12/18) from sarcoma and carcinoma patients and 8% (2/26) from normal controls were positive to the antigen by complement fixation.
D000912:Antibodies, Neoplasm / Q000032:analysis; D000951:Antigens, Neoplasm / Q000302:isolation & purification*; D002277:Carcinoma / Q000276:immunology; D002460:Cell Line; D003168:Complement Fixation Tests; D006801:Humans; D006968:Hypersensitivity, Delayed; D008545:Melanoma / Q000276:immunology*; D012509:Sarcoma / Q000276:immunology; D012867:Skin / Q000276:immunology
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm